Siv Mjøs

418 total citations
7 papers, 329 citations indexed

About

Siv Mjøs is a scholar working on Cancer Research, Obstetrics and Gynecology and Reproductive Medicine. According to data from OpenAlex, Siv Mjøs has authored 7 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cancer Research, 4 papers in Obstetrics and Gynecology and 3 papers in Reproductive Medicine. Recurrent topics in Siv Mjøs's work include Cancer Genomics and Diagnostics (4 papers), Endometrial and Cervical Cancer Treatments (4 papers) and Ovarian cancer diagnosis and treatment (3 papers). Siv Mjøs is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Endometrial and Cervical Cancer Treatments (4 papers) and Ovarian cancer diagnosis and treatment (3 papers). Siv Mjøs collaborates with scholars based in Norway, Germany and United States. Siv Mjøs's co-authors include Camilla Krakstad, Erling A. Høivik, Helga B. Salvesen, Anne M. Øyan, Elisabeth Wik, Even Birkeland, Jone Trovik, Lars A. Akslen, Kanthida Kusonmano and Maria B. Ræder and has published in prestigious journals such as PLoS ONE, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Siv Mjøs

7 papers receiving 325 citations

Peers

Countries citing papers authored by Siv Mjøs

Since Specialization

Citations

This map shows the geographic impact of Siv Mjøs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siv Mjøs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siv Mjøs more than expected).

Fields of papers citing papers by Siv Mjøs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siv Mjøs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siv Mjøs. The network helps show where Siv Mjøs may publish in the future.

Co-authorship network of co-authors of Siv Mjøs

This figure shows the co-authorship network connecting the top 25 collaborators of Siv Mjøs. A scholar is included among the top collaborators of Siv Mjøs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siv Mjøs. Siv Mjøs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	PIK3CA Amplification Associates with Aggressive Phenotype but Not Markers of AKT-MTOR Signaling in Endometrial Carcinoma 2018 ·Clinical Cancer Research ·Frederik Holst, Henrica M.J. Werner, Siv Mjøs, Erling A. Høivik, Kanthida Kusonmano, Elisabeth Wik, Anna Berg, Even Birkeland, William J. Gibson, Mari K. Halle, Jone Trovik, Andrew D. Cherniack, Karl-Henning Kalland, Gordon B. Mills, Christian F. Singer, Camilla Krakstad, Rameen Beroukhim, Helga B. Salvesen	21
2	PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer 2017 ·Scientific Reports ·Siv Mjøs, Henrica M.J. Werner, Even Birkeland, Frederik Holst, Anna Berg, Mari K. Halle, Ingvild L. Tangen, Kanthida Kusonmano, Karen K. Mauland, Anne M. Øyan, Karl‐Henning Kalland, Aurélia E. Lewis, Gordon B. Mills, Camilla Krakstad, Jone Trovik, Helga B. Salvesen, Erling A. Høivik	23
3	Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients 2014 ·Oncotarget ·Anna Berg, Erling A. Høivik, Siv Mjøs, Frederik Holst, Henrica M.J. Werner, Ingvild L. Tangen, Amaro Taylor‐Weiner, William J. Gibson, Kanthida Kusonmano, Elisabeth Wik, Jone Trovik, Mari K. Halle, Anne M. Øyan, Karl-Henning Kalland, Andrew D. Cherniack, Rameen Beroukhim, Ingunn M. Stefansson, Gordon B. Mills, Camilla Krakstad, Helga B. Salvesen	40
4	Lack of Estrogen Receptor-α Is Associated with Epithelial–Mesenchymal Transition and PI3K Alterations in Endometrial Carcinoma 2013 ·Clinical Cancer Research ·Elisabeth Wik, Maria B. Ræder, Camilla Krakstad, Jone Trovik, Even Birkeland, Erling A. Høivik, Siv Mjøs, Henrica M.J. Werner, Monica Mannelqvist, Ingunn M. Stefansson, Anne M. Øyan, Karl H. Kalland, Lars A. Akslen, Helga B. Salvesen	115
5	High Phospho-Stathmin(Serine38) Expression Identifies Aggressive Endometrial Cancer and Suggests an Association with PI3K Inhibition 2013 ·Clinical Cancer Research ·Elisabeth Wik, Even Birkeland, Jone Trovik, Henrica M.J. Werner, Erling A. Høivik, Siv Mjøs, Camilla Krakstad, Kanthida Kusonmano, (unknown), Ingunn M. Stefansson, Frederik Holst, Kjell Petersen, Anne M. Øyan, Ronald Simon, Karl H. Kalland, William Ricketts, Lars A. Akslen, Helga B. Salvesen	35
6	KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer 2012 ·British Journal of Cancer ·Even Birkeland, Elisabeth Wik, Siv Mjøs, Erling A. Høivik, (unknown), (unknown), Kanthida Kusonmano, Kjell Petersen, Maria B. Ræder, Frederik Holst, Anne M. Øyan, Karl‐Henning Kalland, Lars A. Akslen, Ronald Simon, Camilla Krakstad, Helga B. Salvesen	66
7	High-Throughput Mutation Profiling of Primary and Metastatic Endometrial Cancers Identifies KRAS, FGFR2 and PIK3CA to Be Frequently Mutated 2012 ·PLoS ONE ·Camilla Krakstad, Even Birkeland, Danila Seidel, Kanthida Kusonmano, Kjell Petersen, Siv Mjøs, Erling A. Høivik, Elisabeth Wik, Mari K. Halle, Anne M. Øyan, Karl‐Henning Kalland, Henrica M.J. Werner, Jone Trovik, Helga B. Salvesen	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact